Enter company code or name
"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Key data
Status
ActiveKRS number
0000130826REGON
01576517100000NIP/VAT code
5222734952VAT registration date
01/08/2004VAT status
ActiveBankruptcy proceedings
No proceedings"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
UL. KRAKOWIAKÓW 46, 02-255, WARSZAWA, POLSKASee on map
Website
-
01/07/202406/06/202331/08/202201/07/202102/07/202019/06/201909/08/201803/07/201706/07/201601/07/201501/07/201402/07/201309/07/201206/07/201125/06/201003/07/200904/07/200805/07/200719/06/200612/09/200512/09/200512/09/2005Incorporation date
12/09/2002Share capital
6,050,000.00 PLNPrimary activity
Wholesale of pharmaceutical goodsRepresentatives
5Representatives rights
DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE LUB JEDEN CZŁONEK ZARZĄDU ŁĄCZNIE Z PROKURENTEM;Representatives
Business linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
A****** P**** P******** | Member of the management board |
L*** B* S**** | Member of the management board |
M****** R*******-H*** | Member of the management board |
T**** H***** | Member of the management board |
ANDRZEJ PAWEŁ POPKOWSKI | Member of the management board |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
5,615,539Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) |
| Liquidity ratio |
| Net profitability (%) |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2020 |
|---|
| 501,957,716 |
| 3,412,324 |
| 2,270,907 |
| 0.07 |
| 1.18 |
| 0.45 |
| 36,571,692 |
| 200,917,180 |
| 0 |
| - |
| 2021 |
|---|
| 501,957,716 |
| 3,412,324 |
| 2,270,907 |
| 0.07 |
| 1.18 |
| 0.45 |
| 36,571,692 |
| 200,917,180 |
| 0 |
| - |
| 2022 |
|---|
| 683,972,067 |
| 7,360,943 |
| 5,615,539 |
| 0.06 |
| 1.16 |
| 0.82 |
| 42,187,231 |
| 240,290,478 |
| 0 |
| - |
| 2022 |
|---|
| 683,972,067 |
| 7,360,943 |
| 5,615,539 |
| 0.06 |
| 1.16 |
| 0.82 |
| 42,187,231 |
| 240,290,478 |
| 0 |
| - |
2022
Turnover (zł)
683,972,067 zł
36 % *
Profit before tax (zł)
7,360,943 zł116 % *
Net Profit (zł)
5,615,539 zł147 % *
Working capital requirement (%)
0.06 
-14.29 % *
Liquidity ratio
1.16 
-1.69 % *
Net profitability (%)
0.82 %82.22 % *
Equity (zł)
42,187,231 zł15 % *
Current liabilities (zł)
240,290,478 zł20 % *
Non current liabilities (zł)
0 zł
- *
Non-current Assets (zł)
-Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
"NOVO NORDISK PHARMACEUTICAL SERVICES" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
01/07/2024 | OD 01.01.2023 DO 31.12.2023 |
06/06/2023 | OD 01.01.2022 DO 31.12.2022 |
31/08/2022 | OD 01.01.2021 DO 31.12.2021 |
01/07/2021 | OD 01.01.2020 DO 31.12.2020 |
02/07/2020 | OD 01.01.2019 DO 31.12.2019 |
Summary
People
Fin. data
Credit